Gastroenterology Month in Review: November 2023 : comparemel

November’s Gastroenterology Month in Review features an FDA approval, the discontinuation of a phase 3 clinical program, and news about Clostridioides difficile testing and risk factors.

Related Keywords

North Carolina , United States , , Data Monitoring Committee , Kindex Pharmaceuticals , Phathom Pharmaceutical , Data Monitoring , Induction Study , Case Safety Reports , Gastroenterology , C Diff , Ccdi , Clostridioides Difficile , Erosive Esophagitis , Gerd , Vonoprazan , Cobitolimod , Conclude , Testing , Antibiotics , Ciprofloxacin , Ceftriaxone , Piperacillin , Tazobactam ,